Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  3, 1016 - 1020 (1997)
doi:10.1038/nm0997-1016

Distinct sites of intracellular production for Alzheimer's disease Abold beta40/42 amyloid peptides

Tobias Hartmann1, Sophie C. Bieger2, Babara Brühl3, Pentti J. Tienari4, Nobuo Ida1, David Allsop5, Gareth W. Roberts5, Colin L. Masters6, Carlos G. Dotti7, Klaus Unsicker3 & Konrad Beyreuther1

  1Zentrum fur Molekulare Biologic der Universitat Heidelberg (ZMBH), INF282, D-69120 Heidelberg, Germany

  2Department of Anatomy & Neurobiology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H2

  3Department of Anatomy & Cell Biology, INF307, University of Heidelberg, D-69120 Heidelberg, Germany

  4Department of Neurology, University of Helsinki, Haartmaninkatu, Fin-00290 Helsinki, Finland

  5SmithKline Beecham, New Frontier Science Park, Harlow, Essex CM19 5AW, UK

  6Department of Pathology, University of Melbourne, Parkville, Victoria 3052, Australia

  7European Molecular Biology Laboratory (EMBL), Mayerhofstrasse 1, D-69012 Heidelberg, Germany

The Alzheimer amyloid precursor protein (APP) is cleaved by several proteases, the most studied, but still unidentified ones, are those involved in the release of a fragment of APP, the amyloidogenic beta-protein Abeta. Proteolysis by bold gamma-secretase is the last processing step resulting in release of Abeta. Cleavage occurs after residue 40 of Abeta [Abeta(1−40)], occasionally after residue 42 [Abeta(1−42)]. Even slightly increased amounts of this Abeta(1−42) might be sufficient to cause Alzheimer's disease (AD) (reviewed in ref. 1, 2). It is thus generally believed that inhibition of this enzyme could aid in prevention of AD. Unexpectedly we have identified in neurons the endoplasmic reticulum (ER) as the site for generation of Abeta(1−42) and the trans-Golgi network (TGN) as the site for Abeta(1−40) generation. It is interesting that intracellular generation of Abeta seemed to be unique to neurons, because we found that nonneuronal cells produced significant amounts of Abeta(1−40) and Abeta(1−42) only at the cell surface. The specific production of the critical Abeta isoform in the ER of neurons links this compartment with the generation of Abeta and explains why primarily ER localized (mutant) proteins such as the presenilins3 could induce AD. We suggest that the earliest event taking place in AD might be the generation of Abeta(1−42) in the ER.

REFERENCES
  1. Younkin, S.G. Evidence that A beta 42 is the real culprit in Alzheimer's disease. Ann. Neural. 37, 287−288 (1995). | ChemPort |
  2. Hardy, J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosd. 20, 154−159 (1997). | Article | ChemPort |
  3. Kovacs, D.M. et al. Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Med. 2, 224−229 (1996). | Article | PubMed  | ISI | ChemPort |
  4. Ida, N. et al. Analysis of heterogeneous bA4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive western blot assay. J. Biol. Chem. 271, 22908−22914 (1996). | Article | PubMed  | ISI | ChemPort |
  5. Hartmann, T. et al. Alzheimer's disease beta A4 protein release and amyloid precursor protein sorting are regulated by alternative splicing. J. Biol. Chem. 271, 13208−13214 (1996). | Article | PubMed  | ISI | ChemPort |
  6. De Strooper, B. et al. Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence. EMBO J. 14, 932−4938 (1995).
  7. Simons, M. et al. Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons. J. Neurosd. 16, 899−908 (1996). | ChemPort |
  8. Tienari, P.J. et al. The beta-amyloid domain is essential for axonal sorting of amyloid precursor protein. EMBO J. 15, 5218−5229 (1996). | PubMed  | ISI | ChemPort |
  9. Yamazaki, T., Selkoe, D.J. & Koo, E.H. Trafficking of cell surface beta-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons. J. Cell Biol. 129, 431−442 (1995). | Article | PubMed  | ISI | ChemPort |
  10. Haass, C. et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359, 322−325 (1992). | Article | PubMed  | ISI | ChemPort |
  11. Haass, C. et al. Normal cellular processing of the beta-amyloid precursor protein results in the secretion of the amyloid beta peptide and related molecules. Ann. N. Y. Acad. Sci. 695, 109−116 (1993). | PubMed  | ISI | ChemPort |
  12. Shoji, M. et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258, 126−129 (1992). | PubMed  | ISI | ChemPort |
  13. Suzuki, N. et al. An increased percentage of long amyloid beta protein secreted by familial amyloid b protein precursor (bAPP717) mutants. Science 264, 1336−1340 (1994). | PubMed  | ISI | ChemPort |
  14. Ida, N., Masters, C.L. & Beyreuther, K. Rapid cellular uptake of Alzheimer amyloid bA4 peptide by cultured human neuroblastoma cells. FEBS Lett. 394, 174−178 (1996). | Article | PubMed  | ISI | ChemPort |
  15. Klafki, H.W., Paganetti, P.A., Sommer, B. & Staufenbiel, M. Calpain inhibitor I decreases beta A4 secretion from human embryonal kidney cells expressing beta-amyloid precursor protein carrying the APP670/671 double mutation. Neurosd. Lett. 201, 29−32 (1995). | Article | ChemPort |
  16. Higaki, J., Quon, D., Zhong, Z. & Cordell, B. Inhibition of beta-amyloid formation identifies proteolytic precursors and subcellular site of catabolism. Neuron 14, 651−659 (1995). | PubMed  | ISI | ChemPort |
  17. Allsop, D. et al. Studies on inhibition of beta-amyloid formation in APP-751-transfected IMR-32 cells, and SPA4CT transfected SHSY5Y cells. in Alzheimer's Disease: Biology, Diagnosis and Therapeutics (eds. Iqbal, K., Winblad, B., Nishimura, T., Takeda, M. & Wisiniewski, H.M.) 717−727 (Wiley & Sons, Chichester, 1997).
  18. Fuller, S.J. et al. Intracellular production of beta A4 amyloid of Alzheimer's disease: Modulation by phosphoramidon and lack of coupling to the secretion ofthe amyloid precursor protein. Biochemistry 34, 8091−8098 (1995). | PubMed  | ISI | ChemPort |
  19. Tienari, P.J. et al. Intracellular and secreted Alzheimer's beta-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. Proc. Nat. Acad. Sci. USA 94, 4125−4130 (1997). | Article | PubMed  | ChemPort |
  20. Turner, R.S., Suzuki, N., Chyung, A.S.C., Younkin, S.G. & Lee, V.M.Y. Amyloids beta(40) and beta(42) are generated intracellularly in cultured human neurons and their secretion increases with maturation. J. Biol. Chem. 271, 8966−8970 (1996). | Article | PubMed  | ISI | ChemPort |
  21. Wild-Bode, C. et al. Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42. J. Biol. Chem. 272, 16085−16088 (1997). | Article | PubMed  | ChemPort |
  22. Scheuner, D. et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864−870 (1996). | Article | PubMed  | ISI | ChemPort |
  23. Dyrks, T. et al. Generation of beta A4 from the amyloid protein precursor and fragments thereof. FEBS Lett. 335, 89−93 (1993). | Article | PubMed  | ISI | ChemPort |
  24. Haass, C. et al. beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268, 3021−3024 (1993). | PubMed  | ISI | ChemPort |
  25. Citron, M. et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Med. 3, 67−72 (1997). | Article | PubMed  | ISI | ChemPort |
  26. Gabuzda, D., Busciglio Chen, L.B., Matsudaira, P. & Yankner, 8.A. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269, 13623−13628 (1994). | PubMed  | ISI | ChemPort |
  27. Jarrett, J.T., Berger, E.P. & Lansbury, P.T., Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693−4697 (1993). | PubMed  | ISI | ChemPort |
  28. Bretscher, M.S. & Munro, S. Cholesterol and the Golgi apparatus. Science 261, 1280−1281 (1993). | PubMed  | ISI | ChemPort |
  29. Olkkonen, V.M., Liljestrom, P., Garoff, H., Simons, K. & Dotti, C.G. Expression of heterologous proteins in cultured rat hippocampal neurons using the Semliki Forest virus vector. J. Neurosci. Res 35, 445−451 (1993). | PubMed  | ISI | ChemPort |
  30. Mönning, U. et al. Extracellular matrix influences the biogenesis of amyloid precursor protein in microglial cells. J. Biol. Chem. 270, 7104−7110 (1995). | Article | PubMed  | ISI |
  31. Hayat, M. ed. Fixation for Electron Microscopy. (Academic Press, New York, 1981).
  32. Danscher, G. Localization of gold in biological tissue: A photochemical method for light and electron microscopy. Histochemistry 71, 81−88 (1981). | PubMed  | ISI | ChemPort |
  33. van de Plas, P. & Leunissen, J.L. Ultrasmall gold probes: Characteristics and use in immuno(cyto)chemical studies. Methods Cell Biol. 37, 241−257 (1993). | PubMed  | ChemPort |
  34. Heym, C. & Forssmann, W.-G. eds. Techniques in Neuroanatomical Research (Springer-Verlag, Heidelberg, 1981).
  35. Strum, J.M., Wicken, J., Stanbury, J.R. & Karnovsky, M.J. Appearance and function of endogenous peroxidase in fetal rat thyroid. J.Cell Biol. 51, 162−175 (1971). | Article | ChemPort |
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1997 Nature Publishing Group | Privacy policy